Skip to main content
Midas Edge

BELDEN INC.

For the period ended Sep 27, 2026. Filed Oct 29, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 27, 2026 · Filed Oct 29, 2026

BDC$104.90-1.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 5. Other Information

Rule 10b5-1 Trading Plans

The adoption, modification, or termination of contracts for the purchase or sale of our securities by our Section 16 officers and directors for the three months ended September 27, 2026, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (“Rule 10b5-1 Plan”), were as follows:

Name · Title · Action · Date Adopted · Expiration Date · Total SARs · Total Shares
(1)Douglas ZinkVice President and Chief Accounting OfficerAdoption7/31/20265/28/20271,2592,067
(2)Ashish ChandPresident and Chief Executive OfficerAdoption7/31/20268/13/202724,09622,101
(3)Leah TateExecutive Vice President and Chief People and Strategy OfficerAdoption8/3/202611/4/2027—10,000
(4)Hiran BhadraExecutive Vice President and Chief Innovation OfficerAdoption8/3/20261/29/2027—1,239
(5)Brian AndersonExecutive Vice President and Chief Legal and Risk OfficerAdoption8/17/20265/14/202726,2039,943
(6)Jeremy ParksExecutive Vice President and Chief Financial OfficerAdoption9/12/202611/5/2027—15,000

(1) Douglas Zink, Vice President and Chief Accounting Officer, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on July 31, 2026. Mr. Zink's plan provides for the exercise of up to 1,259 stock appreciation rights and the sale of up to 2,067 shares of Belden common stock. The plan expires on May 28, 2027, or upon the earlier completion of all authorized transactions under the plan.

(2) Ashish Chand, President and Chief Executive Officer, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on July 31, 2026. Mr. Chand's plan provides for the exercise of up to 24,096 stock appreciation rights and the sale of up to 22,101 shares of Belden common stock. The plan expires on August 13, 2027, or upon the earlier completion of all authorized transactions under the plan.

(3) Leah Tate, Executive Vice President and Chief People and Strategy Officer, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on August 3, 2026. Mrs. Tate's plan provides for the sale of up to 10,000 shares of Belden common stock. The plan expires on November 4, 2027, or upon the earlier completion of all authorized transactions under the plan.

(4) Hiran Bhadra, Executive Vice President and Chief Innovation Officer, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on August 3, 2026. Mr. Bhadra's plan provides for the sale of up to 1,239 shares. The plan expires on January 29, 2027, or upon the earlier completion of all authorized transactions under the plan.

-28-

(5) Brian Anderson, Executive Vice President and Chief Legal and Risk Officer, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on August 17, 2026. Mr. Anderson's plan provides for the exercise of up to 26,203 stock appreciation rights and the sale of up to 9,943 shares of Belden common stock. The plan expires on May 14, 2027, or upon the earlier completion of all authorized transactions under the plan.

(6) Jeremy Parks, Executive Vice President and Chief Financial Officer, entered into a pre-arranged stock trading plan pursuant to Rule 10b5-1 on September 12, 2026. Mr. Parks' plan provides for the sale of up to 15,000 shares of Belden common stock. The plan expires on November 5, 2027, or upon the earlier completion of all authorized transactions under the plan.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.